Epithelial ovarian carcinoma
- 1 January 1997
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 349 (9045), 113-117
- https://doi.org/10.1016/s0140-6736(96)06071-0
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Limited invasiveness to assess retroperitoneal spread in stage I–II ovarian carcinomaInternational Journal of Gynecology & Obstetrics, 1995
- Conclusions and recommendations from the Helene Harris Memorial Trust Fifth Biennial International Forum on Ovarian Cancer, May 4–7, 1995, Glasgow, UKInternational Journal of Gynecologic Cancer, 1995
- Prospective Multicenter Study on CA 125 in Postmenopausal Pelvic MassesGynecologic Oncology, 1994
- Diagnostic value of pelvic examination, ultrasound, and serum CA 125 in postmenopausal women with a pelvic mass. An international multicenter studyCancer, 1994
- The expression of c-erbB-2 (HER-2/neu) oncogene in invasive ovarian malignanciesInternational Journal of Gynecologic Cancer, 1994
- Analysis of prognostic factors in stage I epithelial ovarian carcinoma: Importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapseAmerican Journal of Obstetrics and Gynecology, 1993
- Ovarian Surface Epithelium and Human Ovarian CancerGynecologic and Obstetric Investigation, 1993
- Second Thoughts about Second-Look Laparotomy in Advanced Ovarian CancerNew England Journal of Medicine, 1990
- Cytoreductive Surgery in Ovarian CarcinomaObstetrics & Gynecology, 1986